{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:48:49Z","timestamp":1790999329769,"version":"4.1.0"},"reference-count":270,"publisher":"Elsevier","isbn-type":[{"value":"9780323915267","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA000620-02"],"award-info":[{"award-number":["DA000620-02"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.apha.2021.10.006","type":"book-chapter","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:47:44Z","timestamp":1648158464000},"page":"275-333","source":"Crossref","is-referenced-by-count":28,"title":["Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond"],"prefix":"10.1016","member":"78","reference":[{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb0010","first-page":"870","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nature Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0015","first-page":"685","article-title":"Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons","volume":"100","author":"Ahluwalia","year":"2000","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0020","first-page":"1064","article-title":"Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation","volume":"28","author":"Akopian","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.apha.2021.10.006_bb0025","first-page":"157","article-title":"Therapeutic potential of cannabis-related drugs","volume":"64","author":"Alexander","year":"2016","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0030","first-page":"5382","article-title":"Adenosine A2A-cannabinoid CB1 receptor heteromers in the hippocampus: Cannabidiol blunts \u03949-tetrahydrocannabinol-induced cognitive impairment","volume":"56","author":"Aso","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0035","first-page":"467","article-title":"CB2: A cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0040","first-page":"1","article-title":"In silico patent searching reveals a new cannabinoid receptor","volume":"27","author":"Baker","year":"2006","journal-title":"Trends in Pharmacological Sciences"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0045","first-page":"558","article-title":"Mitochondrial CB1 receptors regulate neuronal energy metabolism","volume":"15","author":"B\u00e9nard","year":"2012","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0050","first-page":"111","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by \u03949-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0055","first-page":"823","article-title":"Peroxisome proliferator-activated receptors in the cardiovascular system","volume":"129","author":"Bishop-Bailey","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0060","article-title":"Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination","volume":"9","author":"Bl\u00e1zquez","year":"2020","journal-title":"eLife"},{"issue":"29","key":"10.1016\/bs.apha.2021.10.006_bb0065","first-page":"6845","article-title":"Endocannabinoid signaling in rat somatosensory cortex: Laminar differences and involvement of specific interneuron types","volume":"25","author":"Bodor","year":"2005","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0070","first-page":"63","article-title":"Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats","volume":"506","author":"Braida","year":"2004","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0075","first-page":"156","article-title":"5-HT1A receptors are involved in the anxiolytic effect of \u03949-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague\u2013Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"European Journal of Pharmacology"},{"issue":"35","key":"10.1016\/bs.apha.2021.10.006_bb0080","first-page":"11073","article-title":"Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake","volume":"23","author":"Brown","year":"2003","journal-title":"The Journal of Neuroscience"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb0085","first-page":"944","article-title":"Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus","volume":"62","author":"Brusco","year":"2008","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0090","first-page":"450","article-title":"Ultrastructural localization of neuronal brain CB2 cannabinoid receptors","volume":"1139","author":"Brusco","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb0095","article-title":"Endocannabinoid genetic variation enhances vulnerability to THC reward in adolescent female mice","volume":"6","author":"Burgdorf","year":"2020","journal-title":"Science Advances"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0100","first-page":"1021","article-title":"Hippocampal protein kinase C signaling mediates the short-term memory impairment induced by Delta9-tetrahydrocannabinol","volume":"43","author":"Busquets-Garcia","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0105","article-title":"Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain","volume":"9","author":"Caba\u00f1ero","year":"2020","journal-title":"eLife"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0110","first-page":"159","article-title":"Cannabinoids as therapeutic agents for ablating neuroinflammatory disease","volume":"8","author":"Cabral","year":"2008","journal-title":"Endocrine, Metabolic & Immune Disorders Drug Targets"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0115","first-page":"1022","article-title":"Direct and indirect pathways of basal ganglia: a critical reappraisal","volume":"17","author":"Calabresi","year":"2014","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.apha.2021.10.006_bb0120","first-page":"254574","article-title":"G-protein coupled receptor-evoked glutamate exocytosis from astrocytes: Role of prostaglandins","volume":"2014","author":"Cali","year":"2014","journal-title":"Neural Plasticity"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0125","first-page":"223","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0130","first-page":"286","article-title":"Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons","volume":"360","author":"Canseco-Alba","year":"2019","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.apha.2021.10.006_bb0135","first-page":"13","article-title":"Cannabis use, attitudes, and legal status in the U.S.: A review","volume":"104","author":"Carliner","year":"2017","journal-title":"Preventive Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0140","first-page":"102","article-title":"Stereological analysis of Ca2+\/calmodulin-dependent protein kinase II\u03b1-containing dorsal root ganglion neurons in the rat: Colocalization with isolectin Griffonia simplicifolia, calcitonin gene-related peptide, or vanilloid receptor 1","volume":"448","author":"Carlton","year":"2002","journal-title":"Journal of Comparative Neurology"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb0145","first-page":"2452","article-title":"Cannabis constituent synergy in a mouse neuropathic pain model","volume":"158","author":"Casey","year":"2017","journal-title":"Pain"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0150","first-page":"70","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/bs.apha.2021.10.006_bb0155","first-page":"319","article-title":"GPR55: A therapeutic target for Parkinson's disease?","volume":"125","author":"Celorrio","year":"2017","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0160","first-page":"533","article-title":"Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors","volume":"38","author":"Cheer","year":"1999","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0165","first-page":"1154","article-title":"\u03949-THC-caused synaptic and memory impairments are mediated through COX-2 signaling","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"issue":"11","key":"10.1016\/bs.apha.2021.10.006_bb0170","first-page":"3033","article-title":"DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine","volume":"19","author":"Cheng","year":"2004","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.apha.2021.10.006_bb0175","first-page":"30","article-title":"Antagonism of the kappa opioid receptor attenuates THC-induced place aversions in adult male Sprague-Dawley rats","volume":"163","author":"Clasen","year":"2017","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0180","first-page":"586","article-title":"In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity","volume":"277","author":"Compton","year":"1996","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2021.10.006_bb0185","first-page":"36","article-title":"Gonadal hormone modulation of \u25b39-tetrahydrocannabinol-induced antinociception and metabolism in female versus male rats","volume":"152","author":"Craft","year":"2017","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0190","first-page":"117","article-title":"Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences","volume":"23","author":"Crane","year":"2013","journal-title":"Neuropsychology Review"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0195","first-page":"1","article-title":"An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions","volume":"5","author":"Crean","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0200","first-page":"699","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0205","first-page":"108287","article-title":"Differential glutamatergic and GABAergic contributions to the tetrad effects of \u0394(9)-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor","volume":"179","author":"De Giacomo","year":"2020","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb0210","first-page":"1479","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0215","series-title":"Advances in pharmacology","first-page":"249","article-title":"Chapter Eight\u2014Actions and regulation of ionotropic cannabinoid receptors","volume":"Vol. 80","author":"De Petrocellis","year":"2017"},{"issue":"11","key":"10.1016\/bs.apha.2021.10.006_bb0220","first-page":"2065","article-title":"A novel probe for the cannabinoid receptor","volume":"35","author":"Devane","year":"1992","journal-title":"Journal of Medicinal Chemistry"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb1342","first-page":"1743","article-title":"A viral strategy for targeting and manipulating interneurons across vertebrate species","volume":"19","author":"Dimidschstein","year":"2016","journal-title":"Nature Neuroscience"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb0225","first-page":"1700126","article-title":"Linking mitochondria and synaptic transmission: The CB1 receptor","volume":"39","author":"Djeungoue-Petga","year":"2017","journal-title":"BioEssays"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0230","first-page":"117","article-title":"Involvement of 5-hydroxytryptamine1A receptors in \u03949-tetrahydrocannabinol-induced catalepsy-like immobilization in mice","volume":"550","author":"Egashira","year":"2006","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0235","first-page":"239","article-title":"Intracerebral microinjections of delta 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats","volume":"952","author":"Egashira","year":"2002","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0240","first-page":"221","article-title":"Involvement of 5-hydroxytryptamine neuronal system in \u03949-tetrahydrocannabinol-induced impairment of spatial memory","volume":"445","author":"Egashira","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0245","first-page":"50","article-title":"A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55","volume":"39","author":"Elbegdorj","year":"2013","journal-title":"Journal of Molecular Graphics and Modelling"},{"key":"10.1016\/bs.apha.2021.10.006_bb0250","first-page":"107716","article-title":"Subjective effects of combustible, vaporized, and edible cannabis: Results from a survey of adolescent cannabis users","volume":"206","author":"Ewusi Boisvert","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/bs.apha.2021.10.006_bb0255","first-page":"510","article-title":"Cannabinoid CB1 receptor expression in rat spinal cord","volume":"15","author":"Farquhar-Smith","year":"2000","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0260","first-page":"15","article-title":"The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model","volume":"33","author":"Fatemi","year":"2021","journal-title":"Acta Neuropsychiatrica"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0265","first-page":"728","article-title":"The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: An in vivo and in vitro study","volume":"11","author":"Ferraro","year":"2001","journal-title":"Cerebral Cortex"},{"issue":"36","key":"10.1016\/bs.apha.2021.10.006_bb0270","article-title":"Adenosine A2A receptors and A2A receptor heteromers as key players in striatal function","volume":"5","author":"Ferre","year":"2011","journal-title":"Frontiers in Neuroanatomy"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0275","first-page":"1074","article-title":"Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission","volume":"172","author":"Ferreira","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0280","first-page":"678","article-title":"Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain","volume":"19","author":"Finn","year":"2004","journal-title":"The European Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0285","first-page":"409","article-title":"Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of \u03949-tetrahydrocannabinol","volume":"75","author":"Fitton","year":"1982","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0290","article-title":"Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of \u0394-9-tetrahydrocannabinol in rats","volume":"17","author":"Foll","year":"2006","journal-title":"Behavioural Pharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2021.10.006_bb0295","first-page":"1897","article-title":"Vaporized cannabis extracts have reinforcing properties and support conditioned drug-seeking behavior in rats","volume":"40","author":"Freels","year":"2020","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0300","article-title":"Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra","volume":"8","author":"French","year":"1997","journal-title":"Neuroreport"},{"issue":"45","key":"10.1016\/bs.apha.2021.10.006_bb0305","first-page":"10943","article-title":"CB1-dependent long-term depression in ventral tegmental area GABA neurons: A novel target for marijuana","volume":"37","author":"Friend","year":"2017","journal-title":"The Journal of Neuroscience"},{"issue":"10","key":"10.1016\/bs.apha.2021.10.006_bb0310","first-page":"1001","article-title":"Potential of cannabinoid receptor ligands as treatment for substance use disorders","volume":"33","author":"Galaj","year":"2019","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0315","first-page":"134","article-title":"Possible receptor mechanisms underlying cannabidiol effects on addictive-like behaviors in experimental animals","volume":"22","author":"Galaj","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0320","first-page":"54","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"European Journal of Biochemistry"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0325","first-page":"1646","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"Journal of the American Chemical Society"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0330","first-page":"142","article-title":"Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol","volume":"96","author":"Gardner","year":"1988","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0335","first-page":"1146","article-title":"Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors","volume":"22","author":"Ghozland","year":"2002","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0340","first-page":"299","article-title":"Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0345","first-page":"10","article-title":"Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2021.10.006_bb0350","first-page":"1","article-title":"The influence of cannabinoids on learning and memory processes of the dorsal striatum","volume":"125","author":"Goodman","year":"2015","journal-title":"Neurobiology of Learning and Memory"},{"issue":"10","key":"10.1016\/bs.apha.2021.10.006_bb0355","first-page":"502","article-title":"Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat","volume":"17","author":"Goonawardena","year":"2010","journal-title":"Learning & Memory"},{"issue":"14","key":"10.1016\/bs.apha.2021.10.006_bb0360","first-page":"R509","article-title":"The basal ganglia","volume":"10","author":"Graybiel","year":"2000","journal-title":"Current Biology"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0365","first-page":"453","article-title":"Being stoned: A review of self-reported cannabis effects","volume":"22","author":"Green","year":"2003","journal-title":"Drug and Alcohol Review"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0370","first-page":"302","article-title":"Anatomical characterization of the cannabinoid CB1 receptor in cell-type\u2013specific mutant mouse rescue models","volume":"525","author":"Guti\u00e9rrez-Rodr\u00edguez","year":"2017","journal-title":"Journal of Comparative Neurology"},{"issue":"23","key":"10.1016\/bs.apha.2021.10.006_bb0375","first-page":"8932","article-title":"Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats","volume":"20","author":"Hampson","year":"2000","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0380","first-page":"1","article-title":"CB1 receptor activation on VgluT2-expressing glutamatergic neurons underlies \u0394 9-tetrahydrocannabinol (\u0394 9-THC)-induced aversive effects in mice","volume":"7","author":"Han","year":"2017","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0385","first-page":"1039","article-title":"Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD","volume":"148","author":"Han","year":"2012","journal-title":"Cell"},{"issue":"16","key":"10.1016\/bs.apha.2021.10.006_bb0390","first-page":"1466","article-title":"\u03949-tetrahydrocannabinol (\u03949-THC) prevents cerebral infarction via hypothalamic-independent hypothermia","volume":"80","author":"Hayakawa","year":"2007","journal-title":"Life Sciences"},{"issue":"7630","key":"10.1016\/bs.apha.2021.10.006_bb0395","first-page":"555","article-title":"A cannabinoid link between mitochondria and memory","volume":"539","author":"Hebert-Chatelain","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2021.10.006_bb1344","article-title":"Peroxisome proliferator-activated receptors modulate optical brain-stimulation reward in DAT-Cre mice","author":"Hempel","year":"2021","journal-title":"Under review"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0400","first-page":"205","article-title":"An assessment of concurrent cannabidiol and \u03949-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning","volume":"26","author":"Hempel","year":"2018","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0405","first-page":"183","article-title":"The GPR55 ligand L-\u03b1-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation","volume":"23","author":"Henstidge","year":"2009","journal-title":"The FASEB Journal"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0410","first-page":"563","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"The Journal of Neuroscience"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb1340","first-page":"1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0415","first-page":"451","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0420","first-page":"545","article-title":"Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors","volume":"30","author":"Hoffman","year":"2010","journal-title":"The Journal of Neuroscience"},{"issue":"1-2","key":"10.1016\/bs.apha.2021.10.006_bb0425","first-page":"337","article-title":"Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide","volume":"857","author":"Houser","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2021.10.006_bb0430","series-title":"Cannabinoids","first-page":"53","article-title":"Cannabinoid receptor signaling","author":"Howlett","year":"2005"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0435","first-page":"161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacological Reviews"},{"issue":"14","key":"10.1016\/bs.apha.2021.10.006_bb0440","first-page":"1382","article-title":"CB1 cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2021.10.006_bb0445","series-title":"Endocannabinoids","first-page":"59","article-title":"Distribution of the endocannabinoid system in the central nervous system","author":"Hu","year":"2015"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0450","first-page":"e13005","article-title":"Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre mice","volume":"26","author":"Humburg","year":"2021","journal-title":"Addiction Biology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0455","first-page":"159","article-title":"Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors","volume":"383","author":"Imbernon","year":"2014","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0460","first-page":"153","article-title":"The serotonin1A receptor agonist 8-OHDPAT reverses delta 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats","volume":"6","author":"Inui","year":"2004","journal-title":"Neurotoxicity Research"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0465","first-page":"1330","article-title":"Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear","volume":"45","author":"Ivy","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0470","first-page":"420","article-title":"In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor","volume":"296","author":"Iwamura","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0475","first-page":"93","article-title":"Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles","volume":"575","author":"Jansen","year":"1992","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0480","first-page":"880","article-title":"D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor","volume":"308","author":"Jarrahian","year":"2004","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0485","first-page":"300","article-title":"Chronic \u03949-THC in rhesus monkeys: Effects on cognitive performance and dopamine D2\/D3 receptor availability","volume":"364","author":"John","year":"2018","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2021.10.006_bb0490","first-page":"107597","article-title":"The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents","volume":"158","author":"Jordan","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0495","first-page":"208","article-title":"Progress in brain cannabinoid CB(2) receptor research: From genes to behavior","volume":"98","author":"Jordan","year":"2019","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0500","first-page":"405","article-title":"Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist","volume":"16","author":"Justinov\u00e1","year":"2011","journal-title":"Addiction Biology"},{"issue":"11","key":"10.1016\/bs.apha.2021.10.006_bb0505","first-page":"1652","article-title":"Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid","volume":"16","author":"Justinova","year":"2013","journal-title":"Nature Neuroscience"},{"issue":"19","key":"10.1016\/bs.apha.2021.10.006_bb0510","first-page":"6480","article-title":"Differential effects of presynaptic versus postsynaptic adenosine A2A receptor blockade on \u03949-tetrahydrocannabinol (THC) self-administration in squirrel monkeys","volume":"34","author":"Justinov\u00e1","year":"2014","journal-title":"The Journal of Neuroscience"},{"issue":"1-2","key":"10.1016\/bs.apha.2021.10.006_bb0515","first-page":"186","article-title":"The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys","volume":"173","author":"Justinova","year":"2004","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0520","first-page":"135","article-title":"Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys","volume":"169","author":"Justinova","year":"2003","journal-title":"Psychopharmacology"},{"issue":"18","key":"10.1016\/bs.apha.2021.10.006_bb0525","first-page":"2481","article-title":"Localization of the peroxisome proliferator-activated receptor in the brain","volume":"5","author":"Kainu","year":"1994","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0530","first-page":"125","article-title":"Comparisons of \u03949-tetrahydrocannabinol and anandamide on a battery of cognition-related behavior in nonhuman primates","volume":"357","author":"Kangas","year":"2016","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0535","first-page":"354","article-title":"Cannabidiol is an allosteric modulator at mu-and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2021.10.006_bb0540","first-page":"4544","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"The Journal of Neuroscience"},{"issue":"10","key":"10.1016\/bs.apha.2021.10.006_bb0545","first-page":"2273","article-title":"Biphasic effects of Delta9-tetrahydrocannabinol on brain stimulation reward and motor activity","volume":"16","author":"Katsidoni","year":"2013","journal-title":"The international journal of neuropsychopharmacology\/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0550","first-page":"224","article-title":"Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor","volume":"21","author":"Kimura","year":"1998","journal-title":"Biological and Pharmaceutical Bulletin"},{"issue":"1-2","key":"10.1016\/bs.apha.2021.10.006_bb0555","first-page":"57","article-title":"Changes in 5-HT receptor binding induced by tetrahydrocannabinol metabolites in bovine cerebral cortex","volume":"17","author":"Kimura","year":"1996","journal-title":"Research Communications in Alcohol and Substances of Abuse"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0560","first-page":"137","article-title":"Effect of dizocilpine (MK-801) on the catalepsy induced by \u03949-tetrahydrocannabinol in mice","volume":"95","author":"Kinoshita","year":"1994","journal-title":"Journal of Neural Transmission\/General Section JNT"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0565","first-page":"21","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","volume":"98","author":"Kinsey","year":"2011","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0570","first-page":"9","article-title":"Control of glutamate release by complexes of adenosine and cannabinoid receptors","volume":"18","author":"K\u00f6falvi","year":"2020","journal-title":"BMC Biology"},{"issue":"7306","key":"10.1016\/bs.apha.2021.10.006_bb0575","first-page":"622","article-title":"Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0580","first-page":"121","article-title":"\u03949-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus","volume":"59","author":"Laaris","year":"2010","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0585","first-page":"97","article-title":"Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis","volume":"25","author":"Lanciego","year":"2011","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0590","first-page":"48","article-title":"The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A3 adenosine receptor","volume":"79","author":"Lane","year":"2010","journal-title":"Biochemical Pharmacology"},{"issue":"20","key":"10.1016\/bs.apha.2021.10.006_bb0595","first-page":"4790","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"5400","key":"10.1016\/bs.apha.2021.10.006_bb0600","first-page":"401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/bs.apha.2021.10.006_bb0605","first-page":"30","article-title":"Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model","volume":"118","author":"Lefever","year":"2014","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"6","key":"10.1016\/bs.apha.2021.10.006_bb0610","first-page":"993","article-title":"The many faces of PPAR\u03b3","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"issue":"25","key":"10.1016\/bs.apha.2021.10.006_bb0615","first-page":"PL365","article-title":"Genetic differences in \u03949-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains","volume":"58","author":"Lepore","year":"1996","journal-title":"Life Sciences"},{"issue":"23-24","key":"10.1016\/bs.apha.2021.10.006_bb0620","first-page":"2073","article-title":"Conditioned place preference induced by !D\u20139-tetrahydrocannabinol: Comparison with cocaine, morphine, and food reward","volume":"56","author":"Lepore","year":"1995","journal-title":"Life Sciences"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0625","first-page":"452","article-title":"Cannabis and its derivatives: Review of medical use","volume":"24","author":"Leung","year":"2011","journal-title":"The Journal of the American Board of Family Medicine"},{"key":"10.1016\/bs.apha.2021.10.006_bb0630","first-page":"255","article-title":"A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice","volume":"71","author":"Li","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0635","first-page":"38","article-title":"Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice","volume":"43","author":"Li","year":"2021","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0640","first-page":"1","article-title":"Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice","volume":"204","author":"Li","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0645","first-page":"253","article-title":"Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus","volume":"311","author":"Li","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0650","first-page":"125","article-title":"Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism","volume":"126","author":"Lichtman","year":"1996","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0655","first-page":"7","article-title":"The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats","volume":"57","author":"Lichtman","year":"1997","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"24","key":"10.1016\/bs.apha.2021.10.006_bb1341","first-page":"9763","article-title":"Low basal CB2R in dopamine neurons and microglia influences cannabinoid tetrad effects","volume":"21","author":"Liu","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"24","key":"10.1016\/bs.apha.2021.10.006_bb0660","article-title":"Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects","volume":"21","author":"Liu","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0665","first-page":"17410","article-title":"Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference","volume":"7","author":"Liu","year":"2017","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0670","first-page":"519","article-title":"Species differences in cannabinoid receptor 2 (CNR2 gene): Identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands","volume":"8","author":"Liu","year":"2009","journal-title":"Genes, Brain and Behavior"},{"key":"10.1016\/bs.apha.2021.10.006_bb0675","article-title":"Effects of cannabidiol and \u03949-tetrahydrocannabinol in the elevated plus maze in mice","author":"Liu","year":"2021","journal-title":"Behavioural Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb0680","first-page":"861","article-title":"A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice","volume":"13","author":"Long","year":"2010","journal-title":"The international journal of neuropsychopharmacology\/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0685","first-page":"1105","article-title":"Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction","volume":"48","author":"Lupica","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0690","first-page":"225","article-title":"Mechanisms of cannabinoid CB(2) receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area","volume":"42","author":"Ma","year":"2019","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0695","first-page":"12440","article-title":"Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions","volume":"5","author":"Ma","year":"2015","journal-title":"Scientific Reports"},{"issue":"Suppl 1","key":"10.1016\/bs.apha.2021.10.006_bb0700","first-page":"10","article-title":"Cannabinoid receptors: where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0705","first-page":"S23","article-title":"The endocannabinoid system and neuropathic pain","volume":"157","author":"Maldonado","year":"2016","journal-title":"Pain"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0710","first-page":"11","article-title":"The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by \u03949-tetrahydrocannabinol or anandamide","volume":"140","author":"Mallet","year":"1998","journal-title":"Psychopharmacology"},{"issue":"26","key":"10.1016\/bs.apha.2021.10.006_bb0715","first-page":"2431","article-title":"\u03949-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance","volume":"62","author":"Mallet","year":"1998","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0720","first-page":"595","article-title":"Involvement of somatodendritic 5-HT1A receptors in \u03949-tetrahydrocannabinol-induced hypothermia in the rat","volume":"69","author":"Malone","year":"2001","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0725","first-page":"219","article-title":"Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys","volume":"5","author":"Mansbach","year":"1994","journal-title":"Behavioural Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0730","first-page":"815","article-title":"Antagonistic cannabinoid CB1\/dopamine D2 receptor interactions in striatal CB1\/D2 heteromers. A combined neurochemical and behavioral analysis","volume":"54","author":"Marcellino","year":"2008","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0735","first-page":"437","article-title":"Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0740","first-page":"771","article-title":"Advances in the physiology of GPR55 in the central nervous system","volume":"15","author":"Marichal-Cancino","year":"2017","journal-title":"Current Neuropharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2021.10.006_bb0745","first-page":"1747","article-title":"Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain","volume":"17","author":"Mato","year":"2003","journal-title":"European Journal of Neuroscience"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb0750","first-page":"978","article-title":"Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice","volume":"170","author":"McKillop","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"5-6","key":"10.1016\/bs.apha.2021.10.006_bb0755","first-page":"363","article-title":"SR 141716A differentially attenuates the behavioral effects of \u03949-THC in rhesus monkeys","volume":"16","author":"McMahon","year":"2005","journal-title":"Behavioural Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0760","first-page":"21","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annual Review of Psychology"},{"issue":"6","key":"10.1016\/bs.apha.2021.10.006_bb0765","first-page":"993","article-title":"Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain","volume":"24","author":"Melis","year":"2000","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"47","key":"10.1016\/bs.apha.2021.10.006_bb0770","first-page":"10707","article-title":"Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons","volume":"24","author":"Melis","year":"2004","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0775","first-page":"353","article-title":"Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors","volume":"63","author":"Metna-Laurent","year":"2015","journal-title":"Glia"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0780","first-page":"9.59.51","article-title":"Cannabinoid-Induced Tetrad in Mice","volume":"80","author":"Metna-Laurent","year":"2017","journal-title":"Current Protocols in Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0785","first-page":"397","article-title":"Involvement of reduced acetylcholine release in \u03949-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze","volume":"72","author":"Mishima","year":"2002","journal-title":"Life Sciences"},{"issue":"10","key":"10.1016\/bs.apha.2021.10.006_bb0790","article-title":"Genetic Dissection of Behavioural and Autonomic Effects of \u03949-Tetrahydrocannabinol in Mice","volume":"5","author":"Monory","year":"2007","journal-title":"PLoS Biology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0795","first-page":"131","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/bs.apha.2021.10.006_bb0800","first-page":"4926","article-title":"d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor","volume":"97","author":"Mothet","year":"2000","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6441","key":"10.1016\/bs.apha.2021.10.006_bb0805","first-page":"61","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0810","first-page":"235","article-title":"Chronic adolescent \u03949-tetrahydrocannabinol treatment of male mice leads to long-term cognitive and behavioral dysfunction, which are prevented by concurrent cannabidiol treatment","volume":"2","author":"Murphy","year":"2017","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0815","first-page":"183","article-title":"Permissive Role of Dopamine D2 Receptors in the Hypothermia Induced by \u03949-Tetrahydrocannabinol in Rats","volume":"66","author":"Nava","year":"2000","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"6","key":"10.1016\/bs.apha.2021.10.006_bb0820","first-page":"883","article-title":"Endocannabinoids mediate neuron-astrocyte communication","volume":"57","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0825","first-page":"223","article-title":"Expression and distribution of TRPV2 in rat brain","volume":"237","author":"Nedungadi","year":"2012","journal-title":"Experimental Neurology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0830","first-page":"7468","article-title":"CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain","volume":"9","author":"Nent","year":"2019","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0835","first-page":"1435","article-title":"Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders","volume":"44","author":"Newman","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb0840","first-page":"112","article-title":"Inhaled delivery of \u03949-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology","volume":"109","author":"Nguyen","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0845","first-page":"9760","article-title":"The bivalent rewarding and aversive properties of \u03949-tetrahydrocannabinol are mediated through dissociable opioid receptor substrates and neuronal modulation mechanisms in distinct striatal sub-regions","volume":"9","author":"Norris","year":"2019","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0850","first-page":"824","article-title":"Novel time-dependent vascular actions of \u03949-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma","volume":"337","author":"O\u2019Sullivan","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2021.10.006_bb0855","first-page":"35","article-title":"Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse","volume":"323","author":"Oliveira da Cruz","year":"2016","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/bs.apha.2021.10.006_bb0860","first-page":"1063","article-title":"Expression of cannabinoid receptors and their gene transcripts in human blood cells","volume":"23","author":"Onaivi","year":"1999","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb0865","first-page":"1899","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0870","first-page":"2529","article-title":"Combined effects of THC and caffeine on working memory in rats","volume":"165","author":"Panlilio","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"14","key":"10.1016\/bs.apha.2021.10.006_bb0875","first-page":"1394","article-title":"Cannabinoid CB2 Receptors in Health and Disease","volume":"17","author":"Patel","year":"2010","journal-title":"Current Medicinal Chemistry"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0880","first-page":"129","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apha.2021.10.006_bb0885","series-title":"Cannabinoids","first-page":"1","article-title":"Pharmacological actions of cannabinoids","author":"Pertwee","year":"2005"},{"issue":"Suppl. 1","key":"10.1016\/bs.apha.2021.10.006_bb0890","first-page":"S163","article-title":"Cannabinoid pharmacology: The first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0895","first-page":"199","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0900","first-page":"147","article-title":"Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addiction Biology"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0905","first-page":"588","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacological Reviews"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb0910","first-page":"2071","article-title":"Differential changes in GPR55 during microglial cell activation","volume":"583","author":"Pietr","year":"2009","journal-title":"FEBS Letters"},{"issue":"11","key":"10.1016\/bs.apha.2021.10.006_bb0915","first-page":"873","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/bs.apha.2021.10.006_bb0920","first-page":"181","article-title":"Neurobiological mechanisms underlying cannabis-induced memory impairment","volume":"36","author":"Prini","year":"2020","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0925","first-page":"425","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0930","first-page":"963","article-title":"CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl))-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia","volume":"301","author":"Rawls","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0935","first-page":"395","article-title":"N-methyl-d-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-ij]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia","volume":"303","author":"Rawls","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0940","first-page":"227","article-title":"Adenosine A1 and A2A receptors differently control synaptic plasticity in the mouse dorsal and ventral hippocampus","volume":"151","author":"Reis","year":"2019","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb0945","first-page":"3431","article-title":"Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons","volume":"222","author":"Remmers","year":"2017","journal-title":"Brain Structure and Function"},{"key":"10.1016\/bs.apha.2021.10.006_bb0950","series-title":"Vitamins & Hormones","first-page":"421","article-title":"Chapter 16 Endocannabinoid System and Fear Conditioning","volume":"Vol. 81","author":"Resstel","year":"2009"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0955","first-page":"181","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"British Journal of Pharmacology"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb0960","first-page":"2624","article-title":"Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"2-3","key":"10.1016\/bs.apha.2021.10.006_bb0965","first-page":"240","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Letters"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb0970","first-page":"387","article-title":"\u03bc opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb0975","first-page":"823","article-title":"Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus","volume":"21","author":"Rodriguez","year":"2001","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb0980","first-page":"177","article-title":"A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans","volume":"211","author":"Romero-Zerbo","year":"2011","journal-title":"The Journal of Endocrinology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb0985","first-page":"151","article-title":"CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour","volume":"54","author":"Rubino","year":"2008","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2021.10.006_bb0990","first-page":"2036","article-title":"Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral [Delta]9-tetrahydrocannabinol in rats","volume":"32","author":"Rubino","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"25","key":"10.1016\/bs.apha.2021.10.006_bb0995","first-page":"10264","article-title":"Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: Distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions","volume":"33","author":"Ruehle","year":"2013","journal-title":"The Journal of Neuroscience"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb1000","first-page":"1037","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochemical Research"},{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb1005","first-page":"1092","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"17","key":"10.1016\/bs.apha.2021.10.006_bb1010","first-page":"3689","article-title":"CB1-cannabinoid and \u03bc-opioid receptor co-localization on postsynaptic target in the rat dorsal horn","volume":"12","author":"Salio","year":"2001","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb1015","first-page":"748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behavioral Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb1020","first-page":"320","article-title":"\u03949-Tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons","volume":"151","author":"Sano","year":"2008","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb1025","first-page":"1451","article-title":"An optimized approach to study endocannabinoid signaling: Evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors","volume":"140","author":"Savinainen","year":"2003","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb1030","first-page":"278","article-title":"Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system","volume":"142","author":"Schatz","year":"1997","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb1035","first-page":"1","article-title":"Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014","volume":"50","author":"Schauer","year":"2016","journal-title":"American Journal of Preventive Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb1040","first-page":"867","article-title":"Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats","volume":"191","author":"Schramm-Sapyta","year":"2007","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/bs.apha.2021.10.006_bb1343","first-page":"3714","article-title":"Neuronal basic helix-loop-helix proteins (NEX and BETA2\/Neuro D) regulate terminal granule cell differentiation in the hippocampus","volume":"20","author":"Schwab","year":"2000","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb1045","first-page":"226","article-title":"Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats","volume":"64","author":"Sciolino","year":"2011","journal-title":"Pharmacological Research"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb1050","first-page":"3563","article-title":"Astrocytic mechanisms involving kynurenic acid control \u03949-tetrahydrocannabinol-induced increases in glutamate release in brain reward-processing areas","volume":"56","author":"Secci","year":"2019","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.apha.2021.10.006_bb1055","first-page":"1","article-title":"Effects of NMDA and non-NMDA ionotropic glutamate receptors in the medial preoptic area on body temperature in awake rats","volume":"61","author":"Sengupta","year":"2016","journal-title":"Journal of Thermal Biology"},{"issue":"9","key":"10.1016\/bs.apha.2021.10.006_bb1060","first-page":"812","article-title":"The central cannabinoid receptor type-2 (CB2) and chronic pain","volume":"127","author":"Shang","year":"2017","journal-title":"International Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb1065","first-page":"327","article-title":"Astrocytes express functional TRPV2 ion channels","volume":"441","author":"Shibasaki","year":"2013","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb1070","first-page":"2721","article-title":"Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism","volume":"220","author":"Sierra","year":"2015","journal-title":"Brain Structure and Function"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb1075","first-page":"3183","article-title":"\u03b2-Endorphin elevations in the ventral tegmental area regulate the discriminative effects of \u0394-9-tetrahydrocannabinol","volume":"19","author":"Solinas","year":"2004","journal-title":"European Journal of Neuroscience"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb1080","first-page":"2203","article-title":"Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC","volume":"20","author":"Soria","year":"2004","journal-title":"European Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb1085","first-page":"472","article-title":"Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: Implications for the effects of \u03949-tetrahydrocannabinol on spatial memory","volume":"36","author":"Sousa","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb1090","first-page":"601","article-title":"A model of \u03949-tetrahydrocannabinol self-administration and reinstatement that alters synaptic plasticity in nucleus accumbens","volume":"84","author":"Spencer","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"9","key":"10.1016\/bs.apha.2021.10.006_bb1095","first-page":"1268","article-title":"Cannabinoid CB(1) and CB(2) receptor mechanisms underlie cannabis reward and aversion in rats","volume":"176","author":"Spiller","year":"2019","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb1100","first-page":"e184841","article-title":"Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: A crossover trial","volume":"1","author":"Spindle","year":"2018","journal-title":"JAMA Network Open"},{"issue":"32","key":"10.1016\/bs.apha.2021.10.006_bb1105","first-page":"19238","article-title":"Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes*","volume":"271","author":"Stefano","year":"1996","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"10.1016\/bs.apha.2021.10.006_bb1110","first-page":"1017","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb1115","first-page":"795","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/bs.apha.2021.10.006_bb1120","first-page":"734","article-title":"Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism","volume":"152","author":"Sun","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"12","key":"10.1016\/bs.apha.2021.10.006_bb1125","first-page":"2057","article-title":"Short communication: Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids","volume":"15","author":"Szabo","year":"2002","journal-title":"European Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb1130","first-page":"817","article-title":"\u0394-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors","volume":"44","author":"Szkudlarek","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb1135","first-page":"1783","article-title":"Cannabidiol fails to reverse hypothermia or locomotor suppression induced by \u0394(9)-tetrahydrocannabinol in Sprague-Dawley rats","volume":"172","author":"Taffe","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb1140","first-page":"1","article-title":"Effects of \u03949-tetrahydrocannabinol (THC) vapor inhalation in Sprague-Dawley and Wistar rats","volume":"29","author":"Taffe","year":"2021","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2021.10.006_bb1145","first-page":"737","article-title":"Self-administration of \u03949-tetrahydrocannabinol by rats","volume":"11","author":"Takahashi","year":"1979","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/bs.apha.2021.10.006_bb1150","first-page":"18","article-title":"\u03949-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: Possible involvement of induced levels of PPAR\u03b1 in MDA-MB-231 breast cancer cells","volume":"326","author":"Takeda","year":"2014","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/bs.apha.2021.10.006_bb1155","first-page":"1073","article-title":"Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys","volume":"3","author":"Tanda","year":"2000","journal-title":"Nature Neuroscience"},{"issue":"5321","key":"10.1016\/bs.apha.2021.10.006_bb1160","first-page":"2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common \u03bc1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb1165","first-page":"53","article-title":"Neural correlates of interactions between cannabidiol and Delta(9)-tetrahydrocannabinol in mice: implications for medical cannabis","volume":"173","author":"Todd","year":"2016","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb1170","first-page":"25","article-title":"CB1 receptor mediation of cannabinoid behavioral effects in male and female rats","volume":"172","author":"Tseng","year":"2004","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb1175","first-page":"969","article-title":"Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation","volume":"93","author":"Tsou","year":"1999","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb1180","first-page":"436","article-title":"A behavioural model to reveal place preference to \u03949-tetrahydrocannabinol in mice","volume":"147","author":"Valjent","year":"2000","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb1185","first-page":"133","article-title":"The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders","volume":"480","author":"van der Stelt","year":"2003","journal-title":"European Journal of Pharmacology"},{"issue":"5746","key":"10.1016\/bs.apha.2021.10.006_bb1190","first-page":"329","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"issue":"1-3","key":"10.1016\/bs.apha.2021.10.006_bb1195","first-page":"191","article-title":"Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of \u03949-tetrahydrocannabinol","volume":"94","author":"Vann","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb1200","first-page":"329","article-title":"\u03949Tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice","volume":"314","author":"Varvel","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb1205","first-page":"915","article-title":"Evaluation of CB1 receptor knockout mice in the morris water maze","volume":"301","author":"Varvel","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb1210","first-page":"226","article-title":"Interactions between THC and cannabidiol in mouse models of cannabinoid activity","volume":"186","author":"Varvel","year":"2006","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb1215","first-page":"3178","article-title":"Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior","volume":"26","author":"Vickstrom","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"11","key":"10.1016\/bs.apha.2021.10.006_bb1220","first-page":"2553","article-title":"Regulation of PPAR gamma gene expression by nutrition and obesity in rodents","volume":"97","author":"Vidal-Puig","year":"1996","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb1225","first-page":"121","article-title":"Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation","volume":"38","author":"Villapol","year":"2018","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"7","key":"10.1016\/bs.apha.2021.10.006_bb1230","article-title":"cognitive impairment induced by Delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors","volume":"13","author":"Vi\u00f1als","year":"2015","journal-title":"PLoS Biology"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb1235","first-page":"1357","article-title":"The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells","volume":"288","author":"Waksman","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"8","key":"10.1016\/bs.apha.2021.10.006_bb1240","first-page":"1865","article-title":"Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB(1)\/CB(2) versus GPR55 receptors","volume":"177","author":"Wang","year":"2020","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2021.10.006_bb1245","first-page":"27618","article-title":"Localization of PPAR isotypes in the adult mouse and human brain","volume":"6","author":"Warden","year":"2016","journal-title":"Scientific Reports"},{"issue":"24","key":"10.1016\/bs.apha.2021.10.006_bb1250","first-page":"2456","article-title":"Cannabinoids for medical use: A systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb1255","first-page":"195","article-title":"\u03949-Tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice","volume":"352","author":"Wiebelhaus","year":"2015","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb1260","first-page":"185","article-title":"Cannabinoid pharmacological properties common to other centrally acting drugs","volume":"471","author":"Wiley","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb1270","series-title":"Cannabis","author":"World Health Organization","year":"2021"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb1275","article-title":"GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/bs.apha.2021.10.006_bb1280","first-page":"1160","article-title":"Brain cannabinoid CB\u2082 receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nature Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2021.10.006_bb1285","first-page":"337","article-title":"A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain","volume":"151","author":"Yu","year":"2010","journal-title":"Pain"},{"issue":"18","key":"10.1016\/bs.apha.2021.10.006_bb1290","first-page":"4901","article-title":"Two brain sites for cannabinoid reward","volume":"26","author":"Zangen","year":"2006","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2021.10.006_bb1295","first-page":"1037","article-title":"Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats","volume":"40","author":"Zhang","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2021.10.006_bb1300","article-title":"Repeated cocaine administration upregulates CB2 receptor expression in striatal medium-spiny neurons that express dopamine D1 receptors in mice","author":"Zhang","year":"2021","journal-title":"Acta Pharmacologica Sinica"},{"issue":"46","key":"10.1016\/bs.apha.2021.10.006_bb1305","first-page":"E5007","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb1310","first-page":"752","article-title":"Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats","volume":"22","author":"Zhang","year":"2017","journal-title":"Addiction Biology"},{"key":"10.1016\/bs.apha.2021.10.006_bb1315","first-page":"108538","article-title":"Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice","volume":"189","author":"Zhang","year":"2021","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb1320","first-page":"398","article-title":"CB(2) receptor antibody signal specificity: correlations with the use of partial CB(2)-knockout mice and anti-rat CB(2) receptor antibodies","volume":"40","author":"Zhang","year":"2019","journal-title":"Acta Pharmacologica Sinica"},{"issue":"23","key":"10.1016\/bs.apha.2021.10.006_bb1325","first-page":"9499","article-title":"Absence of \u0394-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice","volume":"21","author":"Zimmer","year":"2001","journal-title":"The Journal of Neuroscience"},{"issue":"10","key":"10.1016\/bs.apha.2021.10.006_bb1330","first-page":"5780","article-title":"Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice","volume":"96","author":"Zimmer","year":"1999","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2021.10.006_bb1335","first-page":"245","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"}],"container-title":["Advances in Pharmacology","Behavioral Pharmacology of Drug Abuse: Current Status"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358921000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358921000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:27:51Z","timestamp":1762360071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358921000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323915267"],"references-count":270,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2021.10.006","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}